ARBs, ACE-Is, or statins after catheter ablation of atrial fibrillation?

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 9, 2007, Pages 947-949

  Deneke, Thomas ^a,b  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

CATHETER ABLATION; ELECTROPHYSIOLOGY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ILLINOIS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY VEINS; RECEPTORS, ANGIOTENSIN; RECURRENCE; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 34548307029     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00917.x     Document Type: Note

References (18)

1. Wijfels MC, Kirchhof CJ, Dorland R, Allessie MA : Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995 92 : 1954 1968.
2. Goette A, Staack T, Röcken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U : Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000 35 : 1669 1677.
3. Ihara M, Urata H, Shirai K, Ideishi M, Hoshino F, Suzumiya J, Kikuchi M, Arakawa K : High cardiac angiotensin-II-forming activity in infracted and non-infarcted human myocardium. Cardiology 2000 94 : 247 253.
4. Dernellis J, Panaretou M : C-reactive protein and paroxysmal atrial fibrillation: Evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001 56 : 375 380.
5. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J : Atrial fibrillation and electrical remodelling: The potential role of inflammation and oxidative stress. Med Sci Monit 2003 9 : RA225 229.
6. Healey JS, Branchuk A, Crystal E, Morillo CA, Gafinkle M, Yusuf S, Connolly SJ : Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. J Am Coll Cardiol 2005 45 : 1832 1839.
7. Al Chekakie MO, Akar JG, Wand F, Al Muradi H, Wu J, Santucci, Varma N, Wilber DJ : The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol 2007 18 : 942 946.
8. Siu CW, Lau CP, Tse HF : Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003 92 : 1343 1345.
9. Richter B, Derntl M, Marx M, Lercher P, Gössinger HD : Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: No effect on ablation outcome after ablation of atrial fibrillation. Am Heart J 2007 153 : 113 119.
10. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K : Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodelling in atrial fibrillation. J Am Coll Cardiol 2003 41 : 2197 2204.
11. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A : Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 2003 107 : 2926 2931.
12. Ueng K-C, Tsai T-P, Yu W-C, Tsai C-F, Lin M-C, Chan K-C, Chen C-Y, Wu D-J, Lin C-S, Chen S-A : Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Eur Heart J 2003 24 : 2090 2098.
13. Anné W, Willems R, van der Merwe N, van de Werf F, Ector H, Heidbüchel H : Atrial fibrillation after radiofrequency ablation of atrial flutter: Preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics. Heart 2004 90 : 1025 1030.
14. Madrid AH, Bueno MG, Rebollo JMG, Marín I, Peña G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C : Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. Circulation 2002 106 : 331 336.
15. Tziakas DN, Chalikias GK, Papanas N, Stakos DA, Chatzikyriakou SV, Maltezos E : Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation. Europace 2007, Epub online.
16. Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RRJ, Chen AC, Baggish AL, ODonoghue M, Lee-Lewandrowski E, Januzzi JL : Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the PRIDE study. Am Heart J 2007 153 : 90 97.
17. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H : Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 2004 20 : 1245 1248.
18. Shroff SC, Ryu K, Martovitz NL, Hoit BD, Stambler BS : Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure. J Cardiovasc Electrophysiol 2006 17 : 534 541.